ZYBT (Zhengye Biotechnology Holding Limited Class A Ordinary Shares) Stock Analysis - SEC Filings

Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) is a publicly traded Healthcare sector company. As of May 21, 2026, ZYBT trades at $0.88 with a market cap of $43.74M and a P/E ratio of 0.00. ZYBT moved +0.00% today. Year to date, ZYBT is -22.78%; over the trailing twelve months it is -88.54%. Its 52-week range spans $0.68 to $14.30. Rallies surfaces ZYBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ZYBT SEC filings?

Rallies organizes ZYBT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ZYBT Key Metrics

Key financial metrics for ZYBT
MetricValue
Price$0.88
Market Cap$43.74M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$14.30
52-Week Low$0.68
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ZYBT News

ZYBT Analyst Consensus

ZYBT analyst coverage data. Average price target: $0.00.

Common questions about ZYBT

Where can I find ZYBT SEC filings?
Rallies organizes ZYBT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ZYBT 10-K and 10-Q filings?
Rallies organizes ZYBT SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ZYBT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ZYBT. It does not provide personalized investment advice.
ZYBT

ZYBT